Brookstone Capital Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.52M Sell
27,446
-132,473
-83% -$11.6M 0.03% 461
2026
Q1
$13.6M Buy
159,919
+1,189
+0.7% +$106K 0.16% 163
2025
Q4
$12.5M Buy
158,730
+15,842
+11% +$1.24M 0.14% 174
2025
Q3
$11.4M Buy
142,888
+17,751
+14% +$1.51M 0.14% 190
2025
Q2
$11.4M Buy
125,137
+6,698
+6% +$611K 0.15% 170
2025
Q1
$11.1M Buy
118,439
+98,984
+509% +$8.86M 0.16% 159
2024
Q4
$1.77M Buy
19,455
+2,089
+12% +$199K 0.03% 399
2024
Q3
$1.8M Buy
17,366
+1,814
+12% +$185K 0.03% 391
2024
Q2
$1.55M Sell
15,552
-1,153
-7% -$106K 0.03% 413
2024
Q1
$1.5M Buy
16,705
+98
+0.6% +$8.3K 0.03% 403
2023
Q4
$1.32M Sell
16,607
-477
-3% -$35.9K 0.03% 403
2023
Q3
$1.25M Sell
17,084
-571
-3% -$42.7K 0.03% 391
2023
Q2
$1.33M Sell
17,655
-740
-4% -$57.3K 0.03% 381
2023
Q1
$1.39M Buy
18,395
+1,176
+7% +$87.4K 0.03% 384
2022
Q4
$1.38M Buy
17,219
+718
+4% +$53.8K 0.03% 371
2022
Q3
$1.14M Buy
16,501
+30
+0.2% +$2.35K 0.03% 371
2022
Q2
$1.29M Buy
16,471
+69
+0.4% +$5.39K 0.03% 358
2022
Q1
$1.32M Buy
16,402
+1,043
+7% +$82.6K 0.03% 351
2021
Q4
$1.3M Sell
15,359
-818
-5% -$63.9K 0.02% 339
2021
Q3
$1.23M Buy
16,177
+400
+3% +$31.8K 0.02% 347
2021
Q2
$1.3M Buy
15,777
+4,219
+37% +$345K 0.02% 321
2021
Q1
$911K Buy
11,558
+2,002
+21% +$157K 0.03% 264
2020
Q4
$817K Buy
9,556
+555
+6% +$45.9K 0.03% 258
2020
Q3
$694K Buy
9,001
+2,744
+44% +$209K 0.03% 235
2020
Q2
$458K Buy
6,257
+543
+10% +$38.6K 0.03% 247
2020
Q1
$379K Buy
5,714
+96
+2% +$6.77K 0.02% 241
2019
Q4
$387K Buy
5,618
+718
+15% +$49K 0.02% 305
2019
Q3
$360K Sell
4,900
-1,438
-23% -$104K 0.02% 314
2019
Q2
$454K Buy
6,338
+79
+1% +$5.61K 0.03% 289
2019
Q1
$429K Buy
6,259
+1
+0% +$65 0.03% 273
2018
Q4
$373K Sell
6,258
-460
-7% -$28.8K 0.03% 200
2018
Q3
$450K Buy
6,718
+1,086
+19% +$72.3K 0.03% 288
2018
Q2
$365K Sell
5,632
-41
-0.7% -$2.68K 0.03% 271
2018
Q1
$407K Buy
5,673
+369
+7% +$26.6K 0.04% 223
2017
Q4
$400K Buy
5,304
+112
+2% +$8.18K 0.04% 210
2017
Q3
$378K Sell
5,192
-115
-2% -$8.29K 0.03% 211
2017
Q2
$393K Buy
5,307
+645
+14% +$47.9K 0.04% 195
2017
Q1
$341K Sell
4,662
-211
-4% -$14.8K 0.03% 198
2016
Q4
$319K Buy
4,873
+877
+22% +$60.1K 0.04% 186
2016
Q3
$296K Buy
3,996
+494
+14% +$36.5K 0.03% 190
2016
Q2
$256K Buy
3,502
+3
+0.1% +$214 0.03% 205
2016
Q1
$246K Sell
3,499
-97
-3% -$6.45K 0.04% 196
2015
Q4
$240K Buy
3,596
+38
+1% +$2.53K 0.05% 139
2015
Q3
$226K Buy
3,558
+143
+4% +$9.34K 0.04% 162
2015
Q2
$223K Buy
3,415
+20
+0.6% +$1.36K 0.03% 216
2015
Q1
$235K Buy
3,395
+34
+1% +$2.35K 0.04% 165
2014
Q4
$233K Buy
+3,361
New +$227K 0.04% 146
2014
Q3
Sell
-2,995
Closed -$204K 165
2014
Q2
$204K Buy
+2,995
New +$201K 0.04% 116

Other funds holding CL

Brookstone Capital Management's CL Position: Q2 2026 in Review

Brookstone Capital Management reduced its Colgate-Palmolive (CL) stake by 83% in Q2 2026, selling an estimated $11.6M and leaving 27,446 shares worth $2.52M. The position accounts for 0.03% of the portfolio, ranked #461.

Brookstone Capital Management first reported a position in CL in Q2 2014 and has held it in 48 quarters since. The position peaked at $13.6M in Q1 2026. 427 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Brookstone Capital Management held 27,446 shares of Colgate-Palmolive worth $2.52M as of Q2 2026.
  • Brookstone Capital Management sold 132,473 Colgate-Palmolive shares in Q2 2026, an estimated $11.6M.
  • Colgate-Palmolive made up 0.03% of Brookstone Capital Management's portfolio in Q2 2026, its #461 holding.
  • Brookstone Capital Management first reported a position in Colgate-Palmolive in Q2 2014 and has held it in 48 quarters since.
  • Brookstone Capital Management's Colgate-Palmolive position peaked at $13.6M in Q1 2026.
  • 427 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Brookstone Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.